Correlation Between Immunovant and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Immunovant and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunovant and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunovant and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Immunovant and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunovant with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunovant and Biomarin Pharmaceutical.
Diversification Opportunities for Immunovant and Biomarin Pharmaceutical
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Immunovant and Biomarin is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Immunovant and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Immunovant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunovant are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Immunovant i.e., Immunovant and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Immunovant and Biomarin Pharmaceutical
Given the investment horizon of 90 days Immunovant is expected to generate 3.01 times more return on investment than Biomarin Pharmaceutical. However, Immunovant is 3.01 times more volatile than Biomarin Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.04 per unit of risk. If you would invest 1,550 in Immunovant on August 24, 2024 and sell it today you would earn a total of 1,137 from holding Immunovant or generate 73.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunovant vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Immunovant |
| Biomarin Pharmaceutical |
Immunovant and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunovant and Biomarin Pharmaceutical
The main advantage of trading using opposite Immunovant and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunovant position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |